Subscribe To
Tonix pharmaceuticals to present at the 2023 thinkequity conference
CHATHAM, N.J., Oct. 12, 2023 (GLOBE NEWSWIRE) — Tonix pharmaceuticals Holding Corp. (Nasdaq: TNXP), a...
October 12, 2023, 11:00 am
Chugai pharmaceutical co., ltd. unsponsored adr (chgcy) is a great choice for 'trend' investors, here's why
If you are looking for stocks that are well positioned to maintain their recent uptrend, Chugai pharmaceutical...
October 12, 2023, 10:31 am
Iterum therapeutics to present data at idweek 2023
DUBLIN, Ireland and CHICAGO, Oct. 12, 2023 (GLOBE NEWSWIRE) -- Iterum Therapeutics plc (Nasdaq: ITRM) (the Company), a clinical-stage ...
October 12, 2023, 9:15 am
Pfizer's lung cancer combination therapy approved by the fda
Pfizer Inc (NYSE:PFE) announced that the United States Food and Drug Administration (FDA) has approved BRAFTOVI (encorafenib) plus MEKTOVI (binimetin...
October 12, 2023, 8:41 am
Palisade bio to participate at the virtual investor ask the ceo conference
Live moderated webcast with J.D. Finley, Chief Executive Officer of Palisade Bio on Wednesday, October 25th at 2:00 PM ET Carlsbad, CA, Oct. 11, 2023 ...
October 11, 2023, 1:05 pm
Conduit pharmaceuticals partners with clinconnect on cocrystal development program for azd1656
Collaboration underscores Conduit’s mission to advance promising treatments by developing assets that have already completed Phase I trials SAN DIEG...
October 11, 2023, 12:30 pm
Ozempic alert: new trial causes davita (dva) stock to plunge 20%
Ozempic may find yet another clinical use. The drug, developed by Danish pharmaceutical giant Novo Nord...
October 11, 2023, 12:28 pm
Arbutus announces multiple abstracts accepted for presentation at aasld – the liver meeting® 2023
Imdusiran data will be highlighted in late breaking presentation WARMINSTER, Pa., Oct. 11, 2023 (GLOBE NEWSWIRE) — Arbutus Biopharma Corporation (Na...
October 11, 2023, 12:05 pm
Pmv pharmaceuticals to present updated phase 1 data on pc14586 at the 2023 aacr-nci-eortc international conference on molecular targets and cancer therapeutics and host a kol webinar
PRINCETON, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) -- PMV pharmaceuticals, Inc. (Nasdaq: PMVP), a precisi...
October 11, 2023, 12:00 pm
Patient with candida krusei infection in matinas biopharma’s oral mat2203 expanded access program achieves complete clinical resolution
BEDMINSTER, N.J., Oct. 11, 2023 (GLOBE NEWSWIRE) — Matinas BioPharma (NYSE American: MTNB), a clinical-stage bio...
October 11, 2023, 11:30 am
Phio pharmaceuticals presents new data for targeting of brd4 with its intasyl™ compound ph-894
–Preclinical data shows melanoma cells treated with PH-894 makes them more recognizable to immune cells, increasing potential for elimination –Pre...
October 11, 2023, 11:30 am
Here's why momentum in olema pharmaceuticals, inc. (olma) should keep going
Olema pharmaceuticals, Inc. (OLMA) made it through our "Recent Price Strength" screen and could be a gr...
October 11, 2023, 10:32 am
Is recursion pharmaceuticals stock a buy now?
Recursion pharmaceuticals is using a novel and promising approach to drug discovery. Its strategy has p...
October 11, 2023, 10:07 am
Tiziana life sciences to present ms treatment at ectrims annual congress
Tiziana Life Sciences Ltd (NASDAQ:TLSA) has announced that a late breaking poster titled, "Treatment Of Six Non-Active Secondary Progressive MS With N...
October 11, 2023, 9:26 am
Reasons to add cardinal health (cah) in your portfolio
Cardinal Health (CAH) continues to gain traction from solid pharmaceutical segment and a diversified pr...
October 11, 2023, 8:17 am
Correction - autolus therapeutics to report third quarter 2023 financial results and host conference call on november 2, 2023
LONDON, Oct. 11, 2023 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (Nasdaq: AUTL), a clinical-stage biopharma...
October 11, 2023, 8:07 am
An2 therapeutics to present new data for epetraborole at idweek 2023
MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (Nasdaq: ANTX), a clinical-stage biopharmaceutical...
October 11, 2023, 12:01 am
Medicinova receives a notice of allowance for a new patent covering the combination of mn-166 (ibudilast) and riluzole for the treatment of amyotrophic lateral sclerosis (als) in canada
LA JOLLA, Calif., Oct. 10, 2023 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company trad...
October 10, 2023, 11:00 pm
Amphastar pharmaceuticals: great growth at a high price
Amphastar pharmaceuticals has implemented aggressive corporate strategies to maximize margins and incre...
October 10, 2023, 9:41 pm
Sellas receives fda orphan drug designation for sls009 for treatment of acute myeloid leukemia
NEW YORK, Oct. 10, 2023 (GLOBE NEWSWIRE) — SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clini...
October 10, 2023, 8:15 pm